Magnesium Intake by Enteral Formulation Affects Serum Magnesium Concentration in Patients Undergoing Hemodialysis

Author(s):  
Kou Kitabayashi ◽  
Suguru Yamamoto ◽  
Ichiei Narita
2008 ◽  
Vol 18 (4) ◽  
pp. 151-159 ◽  
Author(s):  
Yoriko Akizawa ◽  
Sadayuki Koizumi ◽  
Yoshinori Itokawa ◽  
Toshiyuki Ojima ◽  
Yosikazu Nakamura ◽  
...  

2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 1856-1856
Author(s):  
Jiada Zhan ◽  
Taylor Wallace ◽  
Sarah Butts ◽  
Sisi Cao ◽  
Connie Weaver ◽  
...  

Abstract Objectives Most studies used serum magnesium concentration and total urine magnesium as nutrition biomarkers of magnesium, but whether these biomarkers are sensitive to changes in dietary intake of magnesium is uncertain. Whole blood ionized magnesium (iMg2+) is the free bioactive form of magnesium in the body, and therefore it could be more sensitive to the changes in magnesium intake. Thus, we aimed to compare the responses of iMg2+, serum magnesium concentration, and total urine magnesium following an oral dose of magnesium. Methods Healthy adults participated in a randomized, single-blind, placebo-controlled crossover trial. They were randomly assigned to 300 mg of magnesium chloride (MgCl2, ReMag®) or placebo, taken with a low-magnesium breakfast after 8-hours of fasting. Timed blood and urine samples were obtained beginning 15-minutes before breakfast, and then at 0, 0.5, 1, 2, 4, 6, 8, and 24-hours timepoints following breakfast. Pharmacokinetic analyses included area under the curve (AUC), the maximum concentration (Cmax), and the time to maximum concentration (Tmax) for iMg2+, serum magnesium concentration, and total urine magnesium. Data were analyzed using paired t-test and Wilcoxon signed-rank test, and reported as mean ± standard deviation, or as median and range, depending on normality. Results Seventeen participants were included in the data analyses. Responses were observed following MgCl2 compared to placebo for iMg2+ (AUC = 1.51 ± 0.96 vs. 0.84 ± 0.82, and Cmax = 1.38 ± 0.13 vs. 1.32 ± 0.07, both P < 0.05). We saw no response following MgCl2 versus placebo for serum magnesium concentration (AUC = 27.00 [0, 172.93] vs. 14.55 [0, 91.18], and Cmax = 2.38 [1.97, 4.01] vs. 2.24 [1.98, 4.31]), and for total urine magnesium (AUC = 201.74 ± 161.63 vs. 139.30 ± 92.84, and Cmax = 26.12 [12.91, 88.63] vs. 24.38 [13.51, 81.51]), both P > 0.05. Conclusions The response of iMg2+ to a single oral dose of magnesium was more pronounced than the responses of serum magnesium concentration and total urine magnesium. Therefore, iMg2+ may be a more sensitive nutrition biomarker for magnesium intake. Funding Sources Funding for this study was provided through an unrestricted educational grant from Think Healthy Group Inc.


2017 ◽  
Vol 37 (12) ◽  
pp. 1297-1303 ◽  
Author(s):  
D Narasimhulu ◽  
A Brown ◽  
N M Egbert ◽  
M Rojas ◽  
S Haberman ◽  
...  

2010 ◽  
Vol 55 (4) ◽  
pp. B45
Author(s):  
Nisha Bhatt ◽  
George Bayliss ◽  
M. Rachel Sim ◽  
Suzanne Martin ◽  
Jacqueline Wolf ◽  
...  

2019 ◽  
Vol 21 (12) ◽  
pp. 1172-1180 ◽  
Author(s):  
Fernanda Chicharo Chacar ◽  
Marcia Mery Kogika ◽  
Andréa C Ferreira ◽  
Khadine K Kanayama ◽  
Archivaldo Reche

ObjectivesMagnesium has been ‘the forgotten ion’ for many years. Over the past decade, however, the role of magnesium in essential physiological functions and several illness conditions have been elucidated. Nevertheless, the investigation of magnesium in cats with chronic kidney disease (CKD) and nephrolithiasis is yet to be determined. The purpose of this study was to investigate whether CKD cats with nephrolithiasis have changes in total serum magnesium concentrations, and whether magnesium disorders may be associated with other electrolyte disturbances, as well as with prognosis. We also aimed to evaluate whether total serum magnesium concentration differs between CKD cats with and without nephrolithiasis.MethodsTotal serum magnesium concentrations were assessed in 42 cats with CKD with stage 1–4 nephrolithiasis. The correlation between magnesium and other electrolytes, as well as Kaplan–Meier survival analysis, were performed. We also selected 14 control cats with CKD without nephrolithiasis age-matched with 14 cats with CKD with nephrolithiasis.ResultsHypermagnesemia was observed in 16/42 (38.1%) and hypomagnesemia in 6/42 (14.3%) cats. Serum magnesium abnormalities were observed in cats of all stages, and marked hypermagnesemia was noted in cats with stage 4 CKD with nephrolithiasis ( P <0.001). There was a negative correlation between total serum magnesium and ionized calcium ( r = −0.64; P <0.01), and a positive correlation between total serum magnesium and serum phosphorus ( r = 0.58, P = 0.01). Cats with CKD with nephrolithiasis and hypomagnesemia or hypermagnesemia had higher mortality than those with normal total serum magnesium concentration ( P <0.01), regardless of CKD stage. There was no difference in total serum magnesium concentration between CKD cats with and without nephrolithiasis.Conclusions and relevanceCats with CKD with nephrolithiasis have magnesium abnormalities. Hypomagnesemia and hypermagnesemia were associated with an increase in mortality, and thus total serum magnesium abnormalities may be used as prognostic factors in these cases.


2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
Jun Lu ◽  
Yuying Gu ◽  
Meixiang Guo ◽  
Peihong Chen ◽  
Hongtao Wang ◽  
...  

Aim. To investigate the association between serum magnesium levels and microvascular complications among patients with diabetes.Methods. Patients with diabetes were recruited between April 2012 and January 2015. All patients received an assay of serum magnesium concentration, were screened for 24 h albumin excretion rate, and underwent nonmydriatic fundus photography. Albuminuria and retinopathy were defined accordingly. A total of 3,100 patients with normal serum magnesium levels were included in this study.Results. Patients with albuminuria and/or retinopathy had lower levels of serum magnesium than patients without these complications (P<0.001). The prevalence of isolated albuminuria, isolated retinopathy, and combined albuminuria and retinopathy decreased as the concentration of serum magnesium increased. Multiple logistic regression analysis indicated that the odds ratio for isolated albuminuria, isolated retinopathy, and concomitant albuminuria and retinopathy decreased by approximately 20% for every 0.1 mmol/L increase in serum magnesium concentration.Conclusion. Serum magnesium levels were negatively associated with the risk of diabetic microvascular complications among patients with serum magnesium levels within the normal range.


Nutrition ◽  
1997 ◽  
Vol 13 (4) ◽  
pp. 303-308
Author(s):  
Gordon S. Sacks ◽  
Rex O. Brown ◽  
Roland N. Dickerson ◽  
Syamal Bhattacharya ◽  
Phuong-Dung Lee ◽  
...  

2021 ◽  
Vol 39 (Supplement 1) ◽  
pp. e410
Author(s):  
Irina Khomova ◽  
Sofia Ilinskaia ◽  
Ekaterina Kirpichnikova ◽  
Nadezhda Ezhova ◽  
Elena Shavarova ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document